About Us

WEGO HOLDING COMPANY LIMITED (“WEGO”) established in March 1988, and the major business of WEGO focus on medical devices and pharmaceuticals. In addition, WEGO develops some other business such as real estate,  investment and so on. WEGO has 9 industry groups and more than 30 subsidiaries. The main products of WEGO are infusion set& syringe, blood transfusion equipment, heart stent & intracardiac consumableIV catheter & special needle, blood purification equipment and consumables, orthopedic material, operation room equipment and accessories, wound care product, minimally invasive instrument and equipment, ICU product and accessories, high-capacity injection and pharmaceutical, renal product, biological diagnostic reagent, PVC & non-PVC material and so on. WEGO produces more than 30 series, 400 categories and 40,000 specifications products, and has become one of the most reliable suppliers of medical system in the word. At the same time, WEGO energetically takes part in healthcare service and provides renal dialysis service. WEGO’s holding subsidiary ---SHANDONG WEIGAO GROUP MEDICAL POLYMER CO., LIMITED is listed in Hong Kong.

WEGO is the “Preferred Manufacturing Base for New Products Developed by the State High Technology Research Development (863) Program” and the “Key High Technology & New Technological Enterprise under the State Torch Program”. WEGO won the following honorary titles: the Leading Enterprise of the Industry, the National Enterprise of Good Credit, the National Model Enterprise of Independent Innovation, Chinese Powerful Enterprise Top 500, the National Top 100 Medical & Pharmaceutical Industry, Chinese Private Enterprise Top 500, China Patent Shandong Famous Enterprise, the Most Ability of Tender in Medical Devices Industrythe Governor Quality Award of Shandong(2ndCongress).

WEGO insists on adjusting industry structure by technology innovation and improving the ability of independent innovation. WEGO builds a state-level Enterprise technology center, a national engineering laboratory of medical implant devices, a national key laboratory, a academician working center, a post-doctoral working center, a Taishan scholar working center, and cooperates with scientific research institutions, universities and hospitals set up 20 R&D centers or joint laboratories. WEGO builds research institutions in Beijing, Tianjin, Changchun, Shenzhen, and has over 1000 talents working for research, development and management. WEGO has over 50 patents and more than 340 products with independent intellectual property. High-technology and high value added products are more than 80% of total products, including 120 products which reach the advanced international level and leading in China, over 100 products break the foreign monopoly, more than 20 products enter National Torch Program and National 863 Program and so on.

WEGO insists scientific management, implements criteria for excellent performance, builds quality standard system, refines business model, and improves customer satisfaction and competitiveness. WEGO carries out flat management with advanced management thoughts and methods. WEGO implements kinds of information system such as ERP, SRM, BPM, and so on. WEGO builds a perfect information management platform, which improves decision-making , management efficiency and quality. WEGO insists the quality principle of “satisfy and surpass customers’ utmost demand”, and pursues the satisfaction of customers. WEGO passed the certification of ISO9000, ISO13484, CE and GMP, and there are more than 30 products which were approved by FDA. WEGO has been approved by the marketing by persistently implementing brand strategy, adopting high-technology, producing high quality and providing first-class service. Our products are sold in more than 30 provinces and municipalities, and exported to over 70 countries and areas.

WEGO insistently implements the “going out” strategy, and cooperates with international institutions and enterprises. WEGO established strategic and cooperative relations with the World Bank, Medtronic, Nikkiso, Terumo, True Vision, Korea IT and so on. Some R&D centers of WEGO built in America, Japan, Britain, Germany and France, with the purpose of absorbing advanced medical technology globally and improving the ability of independent innovation.

WEGO drives the project construction through establishing industry parks, which can strengthen the transformation of scientific and technological achievements. WEGO has built medicine science and technology industrial park, orthopedic material industrial park, heart stent industrial park, and electronic engineering industrial park.

WEGO insists on undertaking social responsibility, supports social welfare and charities, and promotes the construction of harmonious society. WEGO carries out WEGO Light Action, WEGO Loving Care Project and so on. Meanwhile, WEGO actively subsidizes schools, villages, workers and students with difficulties, the amount of donation added up to over 300 million RMB.

WEGO has always been adhering the mission of “Your health, We care”, insisting the principle of ”Exploitation, Innovation, Pragmatism, consolidation”, promoting WEGO Culture, building the core values of ”Conscience, Integrity, Loyalty” ,  and insisting the strategic principle of ”One Center, Three adjustments”. Our general strategy thought is ”medical device and pharmaceutical as major business, explores other relative industries such as real estate, investment, merges and acquires potential enterprises in relative industries, realizes major business is outstanding, other businesses develop simultaneously”. The plan of WEGO is to enter China’s Top 500 in 2015, enter global ’s Top 500 in 2020, realize the vision of “To be one of the global elites; Pioneer in Asia; Largest in China; Most respectable medical device and medication enterprise”, and make a contribution to Chinese medical and healthcare.